| Stage | LH | % of rev | CDW | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.8B | 100.00% | $6.6B | 100.00% | CDW ×1.72 |
| Gross profit | $1.1B | 29.08% | $1.3B | 20.08% | LH +9.0pp |
| Operating income | $402M | 10.55% | $429M | 6.52% | LH +4.0pp |
| Pre-tax income | $328M | 8.61% | $373M | 5.67% | LH +2.9pp |
| Net income | $263M | 6.91% | $274M | 4.18% | LH +2.7pp |
| Stage | LH | CDW | Gap · A − B |
|---|---|---|---|
| Revenue | $3.8B100.00% | $6.6B100.00% | CDW ×1.72 |
| Gross profit | 29.08%$1.1B | 20.08%$1.3B | LH +9.0pp |
| Operating income | 10.55%$402M | 6.52%$429M | LH +4.0pp |
| Pre-tax income | 8.61%$328M | 5.67%$373M | LH +2.9pp |
| Net income |
| 6.91%$263M |
| 4.18%$274M |
| LH +2.7pp |